Elixicure‘s over-the-counter (OTC) drug registration has been certified by the U.S. Food and Drug Administration (FDA) for its Elixicure CBD-infused pain relief product. This marks the first, and currently only, OTC topical drug with CBD to be registered and certified to date.
Elixicure is an all-natural, non-addictive pain relief cream developed to help reduce inflammation, swelling, aches, and pains. “We are ecstatic to announce that Elixicure’s Registration has been certified by the FDA,” says Yaniv Kotler, chief of business development at Elixicure. “This is a major milestone in our commitment to quality, and offering customers healthier options for pain relief using effective natural products, as an alternative to opioids and other dangerous pharmaceuticals.”